(NYSE: FNA) Paragon 28's forecast annual revenue growth rate of 16.36% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.25%.
Paragon 28's revenue in 2024 is $225,435,000.On average, 2 Wall Street analysts forecast FNA's revenue for 2024 to be $21,201,040,394, with the lowest FNA revenue forecast at $21,177,482,208, and the highest FNA revenue forecast at $21,224,681,532. On average, 2 Wall Street analysts forecast FNA's revenue for 2025 to be $25,049,236,936, with the lowest FNA revenue forecast at $24,943,473,952, and the highest FNA revenue forecast at $25,154,999,920.
In 2026, FNA is forecast to generate $29,837,189,435 in revenue, with the lowest revenue forecast at $29,837,189,435 and the highest revenue forecast at $29,837,189,435.